Latest Breaking News On - Multicenter trial - Page 1 : comparemela.com

ENGOT-EN20/GOG-3083/XPORT-EC-042 – A Phase III, Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial of Selinexor in Maintenance Therapy After Systemic Therapy for Patients With p53 Wild-Type, Advanced, or Recurrent Endometrial Carcinoma: Rationale, Methods, and Trial Design

Brian Slomovitz, MD, MS, FACOG, presents the study design, rationale, and primary endpoints of ENGOT-EN20/GOG-3083/XPORT-EC-042, which will be evaluating the efficacy of selinexor compared with placebo as maintenance therapy in patients with advanced or recurrent TP53wt endometrial cancer.

Multicenter trialMaintenance therapy after systemicPatients withRecurrent endometrial carcinoma

SPR Therapeutics Announces Completion of Enrollment in the

SPR Therapeutics Announces Completion of Enrollment in the
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

United statesDave folkensMichelle mcdonaldJosh boggsMaria bennettTherapeutics incMulticenter trialPercutaneous peripheral nerve stimulationChief scientific officerChapel hill

SPR Therapeutics Announces Completion of Enrollment in the RESET Clinical Trial of the SPRINT® PNS System for Low Back Pain

SPR Therapeutics Announces Completion of Enrollment in the RESET Clinical Trial of the SPRINT® PNS System for Low Back Pain
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesJosh boggsMaria bennettDave folkensMichelle mcdonaldTherapeutics incAnnounces completionGlow backMulticenter trialPercutaneous peripheral nerve stimulationChief scientific officerChapel hill

Pfizer Presents New Data at IDWeek 2023 Highlighting Advances in Prevention and Treatment of Certain Respiratory Illnesses and Other Infectious Diseases

Pfizer Presents New Data at IDWeek 2023 Highlighting Advances in Prevention and Treatment of Certain Respiratory Illnesses and Other Infectious Diseases
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJames baberKathleen mcelweeAnnaliesa andersonLuis jodarCeciliag carvalhaesElizabeth begierYehuda carmeliPfizer incDrug administrationVaccine researchExchange commissionAdministration site conditionsRespiratory syncytial virus vaccineSenior vice presidentNorthern hemisphere

Pfizer Presents New Data at IDWeek 2023 Highlighting Advances in Prevention and Treatment of Certain Respiratory Illnesses and Other Infectious Diseases

Pfizer Presents New Data at IDWeek 2023 Highlighting Advances in Prevention and Treatment of Certain Respiratory Illnesses and Other Infectious Diseases
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesAnnaliesa andersonKathleen mcelweeLuis jodarYehuda carmeliJames baberElizabeth begierCeciliag carvalhaesVaccine researchPfizer incExchange commissionAdministration site conditionsDrug administrationRespiratory syncytial virus vaccineSenior vice presidentNorthern hemisphere